
Researchers stop brain cell death in Alzheimer’s mice
The research team led by Prof. Bart De Strooper (VIB-KU Leuven/UK Dementia Research Institute), and Dr Sriram Balusu (VIB-KU Leuven) has finally...

Valneva announces extension of existing loan agreement
An add-on loan provides Valneva SE with immediate access to $50m, with an additional $50m available in Q4/2023. According to the vaccine maker, the...

Lilly presents impressing results for Alzheimer's drug donanemab
Donanemab is the second antibody, after Eisai’s/Biogen’s accelarated approved lecanemab, that can slow the progression of dementia in early-stage...

Santhera licences vamorolone rights to Catalyst Pharmaceuticals
Pratteln-based Santhera Pharmaceuticals Holding got a US$90m upfront payment from Catalyst Pharmaceuticals Inc for the Northern America vamorolone...

EU Regulation of Genome Editing in Plants – not yet a law
The EU proposal has a clear message: the requirements for simple genome-edited plants shall be significantly relaxed. There will no longer be the...

Centogene and Lifera kick-off joint venture
Under the contract the joint venture will use German Centogene NV’s multiomics biobank that represents data of 750,000 patients, and Lifera’s...

Pairwise and Bayer collaborate to CRISPR short-stem maize
Following Leaps by Bayer's co-investment in a US$90m Series B financing in Pairwise Plants Services Inc. in 2021,German seed giant Bayer AG has...